Stocks Overview

LAST PRICE
0.4726
TODAY'S CHANGE (%)
Trending Down-0.0224 (-4.5253%)

Bid / Lots
0.4676/ 5
Ask / Lots
0.4700/ 16
Open / Previous Close
0.5056 / 0.4950
Day Range
Low 0.4621
High 0.5056
52 Week Range
Low 0.4621
High 15.8574
Volume
353,692
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 0.495
Time	Volume	SPRC
09:32 ET	23037	0.49
09:34 ET	100	0.4962
09:36 ET	1043	0.49
09:39 ET	390	0.4924
09:41 ET	100	0.49
09:43 ET	400	0.5022
09:48 ET	3234	0.488126
09:50 ET	5204	0.4881
09:54 ET	637	0.4881
09:57 ET	500	0.487249
09:59 ET	1000	0.48765
10:01 ET	4100	0.488
10:03 ET	2000	0.4993
10:06 ET	4943	0.4937
10:08 ET	1000	0.4881
10:10 ET	6144	0.4991
10:12 ET	373	0.4993
10:14 ET	456	0.4992
10:15 ET	200	0.4902
10:17 ET	383	0.49
10:19 ET	410	0.4901
10:21 ET	5965	0.497299
10:26 ET	4500	0.4971
10:33 ET	1000	0.4911
10:35 ET	1800	0.4916
10:37 ET	793	0.491001
10:46 ET	7016	0.496154
10:48 ET	1377	0.496745
10:50 ET	6350	0.4951
10:51 ET	6091	0.4971
10:55 ET	3152	0.4912
10:57 ET	600	0.496999
11:02 ET	200	0.497
11:04 ET	1149	0.494
11:08 ET	3700	0.4991
11:09 ET	1400	0.4992
11:11 ET	650	0.4991
11:15 ET	801	0.4992
11:22 ET	121	0.4988
11:24 ET	100	0.491
11:36 ET	900	0.494
11:42 ET	100	0.4938
11:47 ET	111	0.4941
11:51 ET	723	0.4939
11:56 ET	7794	0.4993
12:00 ET	400	0.4992
12:02 ET	2675	0.4992
12:05 ET	3778	0.4992
12:09 ET	1612	0.496551
12:16 ET	1440	0.495
12:20 ET	1098	0.491
12:25 ET	200	0.4911
12:27 ET	1200	0.491
12:30 ET	2348	0.487613
12:32 ET	1501	0.491
12:36 ET	100	0.491
12:38 ET	490	0.487
12:43 ET	866	0.4887
12:45 ET	7790	0.483
12:48 ET	200	0.4841
12:50 ET	5356	0.485
12:52 ET	5000	0.4866
12:54 ET	250	0.4844
12:56 ET	280	0.4843
12:57 ET	5199	0.4831
12:59 ET	6476	0.4843
01:01 ET	1415	0.4811
01:06 ET	20542	0.4759
01:08 ET	100	0.4801
01:10 ET	3300	0.4843
01:15 ET	150	0.479
01:17 ET	300	0.4791
01:24 ET	300	0.4831
01:30 ET	250	0.4824
01:33 ET	2158	0.4791
01:35 ET	156	0.48
01:37 ET	200	0.4824
01:48 ET	4063	0.4799
01:50 ET	1883	0.4768
01:51 ET	100	0.4769
02:04 ET	400	0.48
02:06 ET	3414	0.4824
02:08 ET	700	0.4822
02:11 ET	1134	0.4821
02:13 ET	500	0.4821
02:15 ET	523	0.4821
02:20 ET	1300	0.4819
02:22 ET	3310	0.4802
02:24 ET	500	0.4802
02:26 ET	400	0.4791
02:27 ET	300	0.479
02:29 ET	556	0.4759
02:31 ET	1330	0.476
02:33 ET	1300	0.4759
02:36 ET	600	0.4759
02:38 ET	5933	0.47
02:40 ET	375	0.474899
02:42 ET	3100	0.4755
02:44 ET	2801	0.4764
02:45 ET	7233	0.4652
02:47 ET	6622	0.4699
02:49 ET	400	0.4708
02:51 ET	1935	0.470701
02:56 ET	920	0.47
02:58 ET	400	0.4672
03:00 ET	955	0.4662
03:02 ET	1300	0.467199
03:03 ET	1700	0.4666
03:05 ET	2064	0.4644
03:07 ET	9294	0.4631
03:09 ET	500	0.4659
03:12 ET	321	0.4659
03:14 ET	1050	0.4651
03:16 ET	722	0.4648
03:18 ET	1000	0.4648
03:23 ET	3393	0.465
03:25 ET	400	0.4653
03:27 ET	1718	0.4656
03:30 ET	1667	0.4661
03:32 ET	4300	0.467
03:34 ET	400	0.467
03:36 ET	900	0.467
03:38 ET	110	0.467
03:39 ET	4495	0.467
03:41 ET	7675	0.4699
03:43 ET	7530	0.4714
03:45 ET	1200	0.471
03:48 ET	640	0.4714
03:50 ET	300	0.47135
03:52 ET	100	0.47135
03:56 ET	800	0.4714
03:57 ET	600	0.4714
03:59 ET	6121	0.4726

Data delayed at least 15 minutes.

Jul 22, 2024
- SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer, from 8:20AM ET on Monday Jul 22, 2024 by Dow Jones
  8:20AM ET on Monday Jul 22, 2024 by Dow Jones
Jul 17, 2024
- SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million, from 7:07AM ET on Wednesday Jul 17, 2024 by Dow Jones
  7:07AM ET on Wednesday Jul 17, 2024 by Dow Jones
Jul 16, 2024
- SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification, from 11:55AM ET on Tuesday Jul 16, 2024 by Dow Jones
  11:55AM ET on Tuesday Jul 16, 2024 by Dow Jones
- SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss, from 6:03AM ET on Tuesday Jul 16, 2024 by Dow Jones
  6:03AM ET on Tuesday Jul 16, 2024 by Dow Jones
Jul 8, 2024
- *DJ SciSparc to Spin off Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Co, from 8:32AM ET on Monday Jul 08, 2024 by Dow Jones
  8:32AM ET on Monday Jul 08, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesSPRC Scisparc Ltd	350.7K	-0.4x	---
United StatesRXEI RXElite Inc	120.0	0.0x	---
United StatesACAN Americann Inc	1.1M	-2.2x	---
United StatesAGGHF Agrios Global Holdings Ltd	90.0	0.0x	---
United StatesVPOR Vapor Group Inc	27.3K	0.0x	---
United StatesPHCG Pure Harvest Corporate Group Inc	169.3K	0.0x	---
As of 2024-07-26

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Contact Information

Headquarters: 20 Raul Wallenberg Street, Tower ATEL AVIV-YAFO, Israel 6971916
Phone: ---
Fax: ---

Executives

Chairman of the Board: Itschak Shrem
Chief Executive Officer, Director: Amitay Weiss
Chief Financial Officer: Oz Adler
Chief Technology Officer: Adi Zuloff-Shani
Director: Moshe Revach

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$350.7K
Revenue (TTM)	$0.00
Shares Outstanding	708.4K
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	$-1.22
Book Value	$10.77
P/E Ratio	-0.4x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Scisparc Ltd
NASDAQ:SPRCUnited States
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Search Criteria

Charts

Recent News

Jul 22, 2024

SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer, from 8:20AM ET on Monday Jul 22, 2024 by Dow Jones

Jul 17, 2024

SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million, from 7:07AM ET on Wednesday Jul 17, 2024 by Dow Jones

Jul 16, 2024

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification, from 11:55AM ET on Tuesday Jul 16, 2024 by Dow Jones

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss, from 6:03AM ET on Tuesday Jul 16, 2024 by Dow Jones

Jul 8, 2024

*DJ SciSparc to Spin off Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Co, from 8:32AM ET on Monday Jul 08, 2024 by Dow Jones

Pharmaceuticals - Generic & Specialty Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar